Sandra Kleiner

Suggest Changes
Learn More
Patients with relapsed or refractory non-Hodgkin’s lymphomas (NHL) and Hodgkin’s disease (HD) with recurrences after an anthracyclin-containing regimen only have a chance of cure of below 10% with(More)
c-Met is the receptor for hepatocyte growth factor/scatter factor (HGF/SF). It mediates multiple cellular responses in development and adult life, and c-Met hyperactivity is associated with malignant(More)